Is knowledge of brain metabolism the key to treating highly glycolytic cancers and metastases?
作者信息
Mathews Edward Henry, Liebenberg Leon
出版信息
Neuro Oncol. 2013 Jun;15(6):649. doi: 10.1093/neuonc/not041. Epub 2013 Apr 17.
Abstract
摘要
相似文献
1
Is knowledge of brain metabolism the key to treating highly glycolytic cancers and metastases?
Neuro Oncol. 2013 Jun;15(6):649. doi: 10.1093/neuonc/not041. Epub 2013 Apr 17.
2
Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma?
Neuro Oncol. 2011 Jan;13(1):3-13. doi: 10.1093/neuonc/noq169. Epub 2010 Dec 10.
3
Neuro-oncology: Glioblastoma--community adjusts to new standard of care.
Nat Rev Neurol. 2012 Mar 20;8(5):244-6. doi: 10.1038/nrneurol.2012.42.
4
Glioblastoma. Part II: Future directions.
Mo Med. 2011 Jul-Aug;108(4):289-91.
5
Does the existing standard of care increase glioblastoma energy metabolism?
Lancet Oncol. 2010 Sep;11(9):811-3. doi: 10.1016/S1470-2045(10)70166-2. Epub 2010 Jul 13.
6
Standards of care for treatment of recurrent glioblastoma--are we there yet?
Neuro Oncol. 2013 Jan;15(1):4-27. doi: 10.1093/neuonc/nos273. Epub 2012 Nov 7.
7
[Permanent cure of glioblastoma multiforme of the brain with metastases into the axillary lymph nodes].
Cesk Neurol Neurochir. 1980 Nov;43(6):353-7.
8
Tumour Treating Fields (TTFs) for Paediatric Brain Tumours, Brain Metastases and other Novel Applications.
J Pak Med Assoc. 2018 Nov;68(11):1729-1731.
9
The impact of recent data on the optimization of standards of care in newly diagnosed glioblastoma.
Semin Oncol. 2011 Dec;38 Suppl 4:S11-20. doi: 10.1053/j.seminoncol.2011.09.007.
10
Standards of care and novel approaches in the management of glioblastoma multiforme.
Chin J Cancer. 2014 Jan;33(1):32-9. doi: 10.5732/cjc.013.10207.
引用本文的文献
1
Improved rodent models of human brain metastases.
Clin Exp Metastasis. 2013 Oct;30(7):949-50. doi: 10.1007/s10585-013-9588-3. Epub 2013 May 18.
本文引用的文献
1
Standards of care for treatment of recurrent glioblastoma--are we there yet?
Neuro Oncol. 2013 Jan;15(1):4-27. doi: 10.1093/neuonc/nos273. Epub 2012 Nov 7.
2
Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients.
Nutrition. 2012 Oct;28(10):1028-35. doi: 10.1016/j.nut.2012.05.001. Epub 2012 Jul 26.
3
Can successful cancer therapies build on what we learn from complex disorders?
Med Hypotheses. 2012 May;78(5):687-9. doi: 10.1016/j.mehy.2012.02.005. Epub 2012 Mar 4.
4
Identification of hypoglycemic states for patients with T1DM using various parameters derived from EEG signals.
Annu Int Conf IEEE Eng Med Biol Soc. 2011;2011:2760-3. doi: 10.1109/IEMBS.2011.6090756.
5
Revival of "unsuccessful" chemotherapeutics for highly glycolytic cancers?
Med Hypotheses. 2011 Dec;77(6):1150. doi: 10.1016/j.mehy.2011.09.020. Epub 2011 Oct 4.
6
Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review.
Front Pharmacol. 2011 Aug 25;2:49. doi: 10.3389/fphar.2011.00049. eCollection 2011.
7
A perspective on cancer cell metastasis.
Science. 2011 Mar 25;331(6024):1559-64. doi: 10.1126/science.1203543.
8
The role of the organ microenvironment in brain metastasis.
Semin Cancer Biol. 2011 Apr;21(2):107-12. doi: 10.1016/j.semcancer.2010.12.009. Epub 2010 Dec 16.
9
High-glycolytic cancers and their interplay with the body's glucose demand and supply cycle.
Med Hypotheses. 2011 Feb;76(2):157-65. doi: 10.1016/j.mehy.2010.09.006. Epub 2010 Oct 14.
Zotero 插件